Chapter 1. Recent Advances in Migraine Therapy

Annual Reports in Medicinal Chemistry

Volumn 32, Issue C, 1997, Pages 1-10

  Branchek, Theresa ^a   Audia, James E ^b  

^a H LUNDBECK A S   (Denmark)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0010513329     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-7743(08)61459-1     Document Type: Article

References (75)

1. Schonen J. In: Sandler M., Ferrari M., and Harmett S. (Eds). Migraine Pharmacology and Genetics (1996), Chapman & Hall, London 231-253
2. Freiberg L., Olesen J., Iversen H.K., and Sperling B. Lancet 339 (1991) 13-17
3. Lance J.W. J. Neurol. Neurosurg. Psychiatry 59 (1995) 641
4. Moskowitz M.A., and Cutrer M. Seminars in Headache Manage 1 (1996) 7-9
5. Goadsby P.J. In: Sandler M., Ferrari M., and Harmett S. (Eds). Migraine Pharmacology and Genetics (1996), Chapman & Hall, London 67-81
6. Feniuk W., Humphrey P.P.A., and Connor H.E. In: Olesen J., and Saxena P. (Eds). 5-Hydroxytryptamine Mechanisms in Primary Headache (1992), Raven Press Ltd, New York 213-219
7. Den Boer M.O., Villalon C.M., Heiligers J.P.C., Humphrey P.P.A., and Saxena P. Brit. J. Pharmacol. 192 (1991) 323-330
8. Buzzi M.G., Moskowitz M.A., Peroutka S.J., and Byun B. Brit. J. Pharmacol. 103 (1991) 1421-1428
9. Lee W.S., and Moskowitz M.A. Brain Res. 626 (1993) 303-305
10. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., et al. Pharmacol. Rev. 46 (1994) 157-204
11. Bonhaus D.W., Bach C., DaSouza A., Salazar R.F.H., et al. Brig. J. Pharmacol. 115 (1995) 622-628
12. Xie E., Bartkowski H., and Chang L.-S. Soc. Neurosci. Abstr. 21 (1995) 774
13. Hope A.G., Downie D.L., Sutherland L., Lambert J.L., et al. Eur. J. Pharmacol. 245 (1993) 187-192
14. Gerald C., Adham N., Kao H.T., Olsen M.A., et al. EMBO Journal 14 (1995) 2806-2815
15. Heidman D.E., Metcalf M.A., Kohen R., and Hamblin M.W. J. Neurochem. 68 (1997) 1372-1381
16. Maricq A.V., Peterson A.S., Brake A.J., Myers R.M., et al. Science 254 (1991) 432-437
17. Boess F.G., and Martin I.L. Neuropharmacology 33 (1994) 275-317
18. Kobilka B.A. Rev. Neurosci. 15 (1992) 87-114
19. Branchek T.A. Med. Chem. Res. 3 (1994) 287-296
20. Liu Y.F., and Albert P.R. J. Biol. Chem. 266 (1991) 23689-23697
21. Zgombick J.M., Borden L.A., Cochran T.L., and Kucharewicz S.A. Mol. Pharmacol. 44 (1993) 575-582
22. Adham N., Borden L.A., Scheckter L.E., Gustafson E.L., et al. Arch. of Pharmacol. 348 (1993) 566-575
23. Adham N., Vaysse P.J.-J., Weinshank R.L., and Branchek T.A. Neuropharmacology 33 (1994) 403-410
24. Fargin A., Raymond J.R., Regen J.W., Cotecchia S., et al. J. Biol. Chem. 264 (1989) 14848-14852
25. Raymond J.R., Albers F.J., Middleton J.P., Lefkowics R.J., et al. J. Biol. Chem. 264 (1991) 372-379
26. Dascal N., Schreibmayer W., Lim N.F., Wang W., et al. Proc. Nat. Acad. Sci. USA 90 (1993) 10235-10239
27. Humphrey P.P.A., and Feniuk W. Trends Pharmacol. Sci. 12 (1991) 444-446
28. Heuring R.E., and Peroutka S.J. J. Neurosci. 7 (1987) 894-903
29. Weinshank R.L., Zgombick J.M., Macchi M.M., Branchek T.A., and Hartig P.R. Proc. Nat. Acad. Sci. USA 89 (1992) 3630-3634
30. Adham N., Romanienko P., Hartig P., Weinshank R.L., and Branchek T.A. Mol. Pharamacol. 41 (1992) 1-7
31. Hartig P.R., Branchek T.A., and Weinshank R.L. Trends Pharmacol. Sci. 13 (1992) 152-159
32. Oksenberg D., Marsters S.A., O'Dowd B.F., Jin H., Havlik S., Peroutka S., and Askenasi A. Nature 360 (1992) 1661
33. Hartig P.R., Hoyer D., Humphrey P.P.A., and Martin G. Trends Pharmacol. Sci. 17 (1996) 103-105
34. Hamel E. I. D. Research Alerts Serotonin 1 (1996) 19-29
35. Starkey S.J., and Skingle M. Neuropharmacology 33 (1994) 393
36. Raiteri M., Maura G., Bonnano G., and Pittaluga A. J. Pharmacol. Exp. Ther. 237 (1991) 644
37. Harel-Dupas C., Cloez I., and Fillion G. J. Neurochem. 56 (1991) 221
38. Moskowitz M.A. In: Sandler M., Ferrari M., and Harnett S. (Eds). Migraine Pharmacology and Genetics (1996), Chapman & Hall, London 144-153
39. Connor H.E., and Beattie D.T. In: Sandler M., Ferrari M., and Harnett S. (Eds). Migraine: Pharmacology and Genetics (1996), Chapman and Hall, London, U. K. 18-31
40. G. R. Martin, A. D. robertson, S. J. MacLennan, D. J. Prentice, A. Honey and V. J. Barrett, Migraine Trust Symposium, London, September 1994
41. Yocca F.D., Buchanan J., Gylys J.A., Hamel E., Iben L.G., Izzarelli D.G., Mahle C.D., Myers R., Noonan J.W., Parker E.M., Williams A.D., Sarbin N., Saxena P., Smith D.W., and Wiener H.L. Cephalalgia 15 Suppl. 14 (1996) 174
42. Leyson J.E., Gommeren W., Luyten W.H.M.L., Vanhoenacker P., Haegeman G., and Lesage A.S. Soc. Neurosci. Abstr. 15 (1995) 1854
43. Visser W.H., Burggraaf J., Muller L.M., Schoemaker R.C., Fowler P.A., Cohen A.F., and Ferrari M.D. Clin. Pharmacol. & Therapeutics 60 (1996) 452-460
44. Ferrari M.D., and Visser W.H. In: Sandler M., Ferrari M., and Harnett S. (Eds). Migraine Pharmacology and Genetics (1996), Chapman & Hall, London 82-93
45. Martin G.R., and Martin R.S. In: Sandler M., Ferrari M., and Harnett S. (Eds). Migraine Pharmacology and Genetics (1996), Chapman & Hall, London 94-108
46. Longmore J., Boulanger C.M., Desta B., Hill R.D., Schofield W.N., and Taylor A.A. Br. J. Clin. Pharmacol. 42 (1996) 431-441
47. Phebus L.A., Johnson K.W., Audia J.E., Cohen M.L., Dressman B.A., Fritz J.E., Kaldor S.W., Krushinski J.H., Schenck K.W., Zgombick J.M., Branchek T.A., Adam N., and Schaus J.M. Neurosci. Abstr. 22 (1996) 1331
48. J. E. Audia, M. L. Cohen, K. W. Johnson and L. A. Phebus, EP 0 705 600 A1(1996)
49. Sciberras D.G., Polvino W.J., Gertz B.J., Cheng H., Stepanavage M., Wittreich J., Olah T., Edwards M., and Mant T. Br. J. Clin. Pharmacol. 43 (1997) 49-54
50. Bates D., Ashford E., and Dawson R. Neurology 44 (1994) 1587-1592
51. Ferrari M.D. Eur. Neurol. 36 suppl.2 (1996) 4-7
52. Martin G.R. Eur. Neurol. 36 suppl.2 (1996) 13-18
53. Dowson A. Eur. Neurol. 36 suppl.2 (1996) 28-31
54. Beattie D.T., and Connor H.E. Eur. J. Pharmacol. 276 (1995) 271-276
55. Gupta P., Brown D., Butler P., Ellis P., Grayson K.L., Land G.C., Macor J.E., Robson S.F., Wythes M.J., and Shepperson N.B. Br. J. Pharmacol. 116 (1995) 2385-2390
56. Sternfeld F., Baker R., Broughton H.B., Guiblin A.R., Jelley R.A., Matassa V.G., Reeve A.J., Beer M.S., Stanton J.A., Hargreaves R.J., Shepheard S.L., Longmore J., Razzaque Z., Graham M.I., Sohal B., and Street L.J. Biorg. & Med. Chem. Letters 6 (1996) 1825-1830
57. Saxena P.R., DeVries P., Wang W., Heiligers J.P.C., Massen Van DenBrink A., Bax W.A., and Yocca F.D. Naunyn-Schmiedberg's Arch. Pharmacol. 355 (1997) 295-302
58. Leysen J.E., Gommeren W., Heylen L., Luyten W.H.M.L., Van De Weyer I., Vanhoenacker P., Haegeman G., Schotte A., Van Gompel P., Wouters R., and Lesage A.S. Mol. Pharmacol. 50 (1996) 1567-1580
59. Adham, Kao H.-T., Schechter L., Bard J., Olsen M., Urquhart D., Durkin M., Hartig P.R., Weinshank R.L., and Branchek T.A. Proc. Nat. Acad. Sci. USA 90 (1993) 408-412
60. Bruinvels A.T., Landwehrmeyer B., Gustafson E., Durkin M., Mengod G., Branchek T.A., Hoyer D., and Palacios J.M. Neuropharmacology 33 (1994) 367-386
61. Adham N., Bard J., Zgombick J.M., Durkin M., Kucharewicz S., Weinshank R.L., and Branchek T.A. Neuropharmacology 36 (1997) in press
62. Johnson K.W., Schaus J.M., Cohen M.L., Audia J.E., Kaldor S.W., Flaugh M.E., Krushinski J.H., Schenck K.W., Kiefer Jr. A.D., Nissen J.S., Dressman B.A., Zgombick J.M., Branchek T.A., Adam N., and Phebus L.A. Soc. Neurosci. Abstr. 22 (1996) 1330
63. K. W. Johnson, J. M. Schaus, M.Durkin, J. E. Audia, S. W. Kaldor, M. E. Flaugh, N. Adham, J. M. Zgombick, M. L. Cohen, T. A. Branchek, L. A. Phebus, Neuroreport, in press.
64. Oleson J., and Oleson I. Headache Treatment and New Drugs (1997), Lippincott-Raven Press, Philadelphia 313
65. Clarke J.M. Brit. Med. J. 1 (1910) 1534-1538
66. Whitty C.W.M. J.Neurol. Neurosurg. Psychiat. 16 (1953) 172-177
67. Tournier-Lasserve E., Iba-Zizen M.T., Romero N., and Bousser M.G. Stroke 22 (1991) 1297-1302
68. Tournier-Lasserve E., Joutel A., Melki J., Wassenbach J., Lathrop G.M., et al. Nature Genetics 3 (1993) 256-259
69. Joutel A., Corpechot C., Ducros A., Vahedi K., Chabriat H., Mouton P., Alamowitch S., et al. Nature 383 (1996) 707-710
70. Grindley T. Nature 383 (1996) 673
71. Lance J.M. In: Sandler M., Ferrari M., and Harnett S. (Eds). Migraine Pharmacology and Genetics (1996), Chapman & Hall, London 287
72. Ophoff R.A., Terwindt G.M., Vergouwe M.N., van Eijk R., Oefner P.J., Hoffman S.M.G., et al. Cell 87 (1996) 543-552
73. Peikert A., Wilimzig C., and Kohne-Vollande R. Cepahalgia 16 (1996) 257-263
74. Sidman R.L., Green M.C., and Appel S.H. Catalog of the neurological mutants of mouse (1965), Harvard University Press, Cambridge
75. Hess E.J. Cell 87 (1996) 1149-1151